Feedback / Questions
adrabetadex (VTS-270) - Mandos Health
https://www.businesswire.com/news/home/20251209951827/en/FDA-Grants-Breakthrough-Therapy-Designation-to-Investigational-Drug-Adrabetadex-for-Individuals-with-Infantile-Onset-Niemann-Pick-Disease-Type-C
Dec 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next